Showing results (81-90 of 158) with videos related to
Sort By:
Pageof 16
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 20, 1975
[Intermittent thrombolytic treatment. Results during severe, chronic arterial diseases]J N Fiessinger, M Aiach, P Lagneau, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1991
Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosisP Toulon, J F Vitoux, J N Fiessinger, et al.Thrombosis Research|May 15, 1983
Antithrombin III synthesis in rat liver parenchymal cellsM Léon, M Aiach, E Coezy, et al.Thrombosis and Haemostasis|April 8, 1998
Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosisC Bachelot-Loza, R Saffroy, D Lasne, et al.Journal of Thrombosis and Haemostasis : JTH|June 29, 2006
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cellsD M Smadja, I Laurendeau, C Avignon, et al.Thrombosis and Haemostasis|February 28, 1986
Heparin-associated thrombocytopenia treatment with low molecular weight heparinJ F Vitoux, J F Mathieu, M Roncato, et al.Transfusion|October 1, 1994
Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasmaN Boeri, S Saleun, E Pelissier, et al.British Journal of Haematology|June 1, 1990
Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutationN de Roux, G Chadeuf, P Molho-Sabatier, et al.The Journal of Biological Chemistry|February 13, 1999
Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombinV Picard, P E Marque, F Paolucci, et al.The Journal of Biological Chemistry|January 8, 2000
The role of Glu(192) in the allosteric control of the S(2)' and S(3)' subsites of thrombinP E Marque, R Spuntarelli, L Juliano, et al.Pageof 16